| 201 |
NGNENeurogene Inc. |
Life Sciences |
0.03 |
$465M |
Unlock rating and forecasts |
| 202 |
ENTXEntera Bio Ltd. |
Life Sciences |
0.09 |
$464M |
Unlock rating and forecasts |
| 203 |
RGNXREGENXBIO Inc. |
Life Sciences |
0.03 |
$457M |
Unlock rating and forecasts |
| 204 |
ARVNARVINAS, INC. |
Life Sciences |
0.27 |
$456M |
Unlock rating and forecasts |
| 205 |
ALLOAllogene Therapeutics, Inc. |
Life Sciences |
0.04 |
$453M |
Unlock rating and forecasts |
| 206 |
NIKANIKA PHARMACEUTICALS, INC |
Life Sciences |
0.17 |
$431M |
Neutral |
-0.80% |
+2.67% |
new |
| 207 |
PRTAPROTHENA CORP PUBLIC LTD CO |
Life Sciences |
0.28 |
$429M |
Unlock rating and forecasts |
| 208 |
AUTLAutolus Therapeutics plc |
Life Sciences |
0.30 |
$426M |
Unlock rating and forecasts |
| 209 |
OVIDOvid Therapeutics Inc. |
Life Sciences |
0.06 |
$420M |
Unlock rating and forecasts |
| 210 |
TLRYTilray Brands, Inc. |
Life Sciences |
0.15 |
$414M |
Neutral |
+0.69% |
+2.44% |
· |
| 211 |
ASMBASSEMBLY BIOSCIENCES, INC. |
Life Sciences |
0.06 |
$409M |
Unlock rating and forecasts |
| 212 |
EIKNEikon Therapeutics, Inc. |
Life Sciences |
0.32 |
$402M |
Unlock rating and forecasts |
| 213 |
PROKPROKIDNEY CORP. |
Life Sciences |
0.02 |
$400M |
Unlock rating and forecasts |
| 214 |
CAPRCAPRICOR THERAPEUTICS, INC. |
Life Sciences |
0.45 |
$390M |
Unlock rating and forecasts |
| 215 |
MYGNMYRIAD GENETICS INC |
Life Sciences |
0.39 |
$381M |
Unlock rating and forecasts |
| 216 |
TKNOAlpha Teknova, Inc. |
Life Sciences |
0.37 |
$380M |
Unlock rating and forecasts |
| 217 |
ZURAZura Bio Ltd |
Life Sciences |
0.19 |
$372M |
Unlock rating and forecasts |
| 218 |
EDITEditas Medicine, Inc. |
Life Sciences |
0.20 |
$361M |
Unlock rating and forecasts |
| 219 |
KYTXKyverna Therapeutics, Inc. |
Life Sciences |
0.62 |
$351M |
Unlock rating and forecasts |
| 220 |
INDPIndaptus Therapeutics, Inc. |
Life Sciences |
0.09 |
$350M |
Neutral |
+0.72% |
+2.57% |
▲ 1 |
| 221 |
FENCFENNEC PHARMACEUTICALS INC. |
Life Sciences |
0.37 |
$350M |
Unlock rating and forecasts |
| 222 |
RZLTRezolute, Inc. |
Life Sciences |
0.37 |
$346M |
Unlock rating and forecasts |
| 223 |
CCCCC4 Therapeutics, Inc. |
Life Sciences |
0.31 |
$340M |
Unlock rating and forecasts |
| 224 |
PRLDPrelude Therapeutics Inc |
Life Sciences |
0.04 |
$334M |
Unlock rating and forecasts |
| 225 |
RLMDRELMADA THERAPEUTICS, INC. |
Life Sciences |
0.37 |
$331M |
Unlock rating and forecasts |
| 226 |
VTVTvTv Therapeutics Inc. |
Life Sciences |
0.14 |
$329M |
Neutral |
+0.93% |
+2.89% |
▼ 1 |
| 227 |
EBSEmergent BioSolutions Inc. |
Life Sciences |
0.56 |
$327M |
Unlock rating and forecasts |
| 228 |
ENTAENANTA PHARMACEUTICALS INC |
Life Sciences |
0.52 |
$323M |
Unlock rating and forecasts |
| 229 |
IRDOpus Genetics, Inc. |
Life Sciences |
0.29 |
$319M |
Unlock rating and forecasts |
| 230 |
TTRXTurn Therapeutics Inc. |
Life Sciences |
0.28 |
$315M |
Unlock rating and forecasts |
| 231 |
IKTInhibikase Therapeutics, Inc. |
Life Sciences |
0.07 |
$300M |
Unlock rating and forecasts |
| 232 |
ARCTArcturus Therapeutics Holdings Inc. |
Life Sciences |
0.19 |
$294M |
Unlock rating and forecasts |
| 233 |
USNAUSANA HEALTH SCIENCES INC |
Life Sciences |
0.28 |
$287M |
Unlock rating and forecasts |
| 234 |
ARTVArtiva Biotherapeutics, Inc. |
Life Sciences |
0.25 |
$286M |
Unlock rating and forecasts |
| 235 |
FULCFulcrum Therapeutics, Inc. |
Life Sciences |
0.01 |
$278M |
Unlock rating and forecasts |
| 236 |
CYPHCYPHERPUNK TECHNOLOGIES INC. |
Life Sciences |
0.16 |
$277M |
Unlock rating and forecasts |
| 237 |
SRZNSurrozen, Inc./DE |
Life Sciences |
0.17 |
$276M |
Unlock rating and forecasts |
| 238 |
AGENAGENUS INC |
Life Sciences |
0.59 |
$272M |
Unlock rating and forecasts |
| 239 |
ELTPELITE PHARMACEUTICALS INC /NV/ |
Life Sciences |
0.23 |
$269M |
Unlock rating and forecasts |
| 240 |
OCGNOcugen, Inc. |
Life Sciences |
0.42 |
$265M |
Unlock rating and forecasts |
| 241 |
ACBAURORA CANNABIS INC |
Life Sciences |
0.16 |
$253M |
Neutral |
+1.09% |
+3.25% |
▼ 1 |
| 242 |
IPSCCentury Therapeutics, Inc. |
Life Sciences |
0.37 |
$248M |
Unlock rating and forecasts |
| 243 |
CATXPerspective Therapeutics, Inc. |
Life Sciences |
0.10 |
$248M |
Unlock rating and forecasts |
| 244 |
LABSTANDARD BIOTOOLS INC. |
Life Sciences |
0.21 |
$247M |
Unlock rating and forecasts |
| 245 |
PALIPALISADE BIO, INC. |
Life Sciences |
0.13 |
$246M |
Unlock rating and forecasts |
| 246 |
VNDAVanda Pharmaceuticals Inc. |
Life Sciences |
0.28 |
$244M |
Unlock rating and forecasts |
| 247 |
LFCRLIFECORE BIOMEDICAL, INC. \DE\ |
Life Sciences |
0.30 |
$242M |
Unlock rating and forecasts |
| 248 |
ABEOABEONA THERAPEUTICS INC. |
Life Sciences |
0.09 |
$240M |
Unlock rating and forecasts |
| 249 |
CABACabaletta Bio, Inc. |
Life Sciences |
0.04 |
$239M |
Unlock rating and forecasts |
| 250 |
AMRNAMARIN CORP PLC\UK |
Life Sciences |
0.05 |
$238M |
Neutral |
+0.85% |
+2.46% |
· |